Consistent with our hypothesis that AM signaling inhibition would result in a decrease in angiogenesis, immunohistochemical staining for CD31 demonstrated that tumor vascularization is deeply disrupted in tumors from animals treated with αAMRs and AM22-52 (Figure 10A). Here, PECAM1 is linked to neoplasm.